CA 19-9 (Cancer antigen 19-9)

Biliary stent combined with iodine-125 intraluminal brachytherapy significantly prolonged SPT compared to stent-alone in patients with advanced pancreatic cancer complicated by obstructive jaundice, although it did not significantly improve survival outcomes. Higher ECOG performance score and higher CA19-9 level after jaundice reduce were associated with poor prognosis.

The PNI, LVI, TNM stage, ALB, CA19-9, age, and CEA were identified as independent perioperative risk factors for long-term survival in gastric cancer patients undergoing gastrectomy. The PNI is an independent factor influencing both short-term complications and long-term survival.

Under ambient conditions (25 °C, 4% relative humidity), the device shows highly repeatable measurement performance. This work provides a label-free, rapid, and non-destructive terahertz sensing platform with strong potential for biosensing and biochemical monitoring.

Physicians need to be aware of such cases, as their management is different from cholangitis due to other causes, which are frequently encountered in clinical practice. IPMN-B requires a detailed imaging workup and definitive surgical resection due to its high risk of malignant transformation.

P1, N=68, Terminated, Zhejiang University | Recruiting --> Terminated; sponsor's decision to change development strategy (the QOD cohort was completed).

The combination of CT with CEA or CA19-9 improves sensitivity for detecting LNM in EGC, supporting personalized treatment planning and demonstrating clinical value.

ICWM extended survival in patients with advanced PC, improved long-term efficacy, controlled local lesions, reduced serum tumor markers, enhanced immune function, and improved short-term outcomes, with a favorable safety profile.

Dynamic postoperative monitoring of serum CEA and AFP enables early prediction and detection of gastric cancer recurrence.

Cinobufacini combined with oxaliplatin-based chemotherapy may enhance short-term efficacy, immune function, and safety in advanced CRC. However, due to limitations of existing RCTs, these findings should be interpreted cautiously, and further large-scale, high-quality trials are required.

Notably, it identifies key signature patterns that improve early-stage (I/II) PDAC diagnosis and perform well with small sample sizes (n = 50). TabPFN-PanMETAI offers a rapid, accurate, and non-invasive tool for early PDAC detection, with strong potential for clinical application.

Tumor T stage, extent of resection, age, CEA, CA199, gender, tumor longest diameter, and differentiation degree are associated with OS after radical gastrectomy. This study constructed an SVM-based prediction model with good precision and developed a corresponding website.

P2, N=42, Recruiting, Gruppo Oncologico del Nord-Ovest